Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Absci (ABSI) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for Absci (ABSI) over the last 5 years, with Dec 2024 value amounting to $41.2 million.

  • Absci's Cash & Equivalents fell 75.19% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 75.19%. This contributed to the annual value of $41.2 million for FY2024, which is 43.05% down from last year.
  • Latest data reveals that Absci reported Cash & Equivalents of $41.2 million as of FY2024, which was down 43.05% from $72.4 million recorded in FY2023.
  • In the past 5 years, Absci's Cash & Equivalents ranged from a high of $252.6 million in FY2021 and a low of $41.2 million during FY2024.
  • Moreover, its 3-year median value for Cash & Equivalents was $60.0 million (2022), whereas its average is $57.8 million.
  • In the last 5 years, Absci's Cash & Equivalents skyrocketed by 261.50% in 2021 and then slumped by 76.26% in 2022.
  • Yearly analysis of 5 years shows Absci's Cash & Equivalents stood at $69.9 million in 2020, then spiked by 261.50% to $252.6 million in 2021, then plummeted by 76.26% to $60.0 million in 2022, then grew by 20.69% to $72.4 million in 2023, then plummeted by 43.05% to $41.2 million in 2024.